NCT04164043

Brief Summary

The Recreation Therapy Wellness Recovery Program conducts group classes which provide repetitive training of foundational skills designed specifically for those with Parkinson's Disease. The course will encourage bigger and faster movements (adapted from the Parkinson Wellness Recovery, PWR!Moves ® program) and education on optimal function.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 6, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2019

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

November 11, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 15, 2019

Completed
Last Updated

March 22, 2023

Status Verified

September 1, 2021

Enrollment Period

11 months

First QC Date

November 11, 2019

Last Update Submit

March 17, 2023

Conditions

Keywords

Recreation TherapyCommunity BasedMovement DisorderWellness Recovery Program

Outcome Measures

Primary Outcomes (47)

  • Sit to Stand Test

    Measures functional muscle strength in the lower limbs. This test is reported in seconds.

    Baseline Measure 1 performed at day 1 after signing consent

  • Sit to Stand Test

    Measures functional muscle strength in the lower limbs. This test is reported in seconds.

    Baseline Measure 2 performed at day 2 after signing consent

  • Sit to Stand Test

    Measures functional muscle strength in the lower limbs. This test is reported in seconds.

    Week 4 post baseline period

  • Sit to Stand Test

    Measures functional muscle strength in the lower limbs. This test is reported in seconds.

    Week 8 post baseline period

  • Sit to Stand Test

    Measures functional muscle strength in the lower limbs. This test is reported in seconds.

    Week 12 post baseline period

  • Timed Floor Transfer Test

    Measures vestibular balance and functional mobility to determine risk of falling. This test is reported in seconds.

    Baseline Measure 1 performed at day 1 after signing consent

  • Timed Floor Transfer Test

    Measures vestibular balance and functional mobility to determine risk of falling. This test is reported in seconds.

    Baseline Measure 2 performed at day 2 after signing consent

  • Timed Floor Transfer Test

    Measures vestibular balance and functional mobility to determine risk of falling. This test is reported in seconds.

    Week 4 post baseline period

  • Timed Floor Transfer Test

    Measures vestibular balance and functional mobility to determine risk of falling. This test is reported in seconds.

    Week 8 post baseline period

  • Timed Floor Transfer Test

    Measures vestibular balance and functional mobility to determine risk of falling. This test is reported in seconds.

    Week 12 post baseline period

  • Timed Up and Go (TUG) test

    Test involves a series of transitional movements including sit to stand, walking, turning and sit to stand. The test is reported in seconds.

    Baseline Measure 1 performed at day 1 after signing consent

  • Timed Up and Go (TUG) test

    Test involves a series of transitional movements including sit to stand, walking, turning and sit to stand. The test is reported in seconds.

    Baseline Measure 2 performed at day 2 after signing consent

  • Timed Up and Go (TUG) test

    Test involves a series of transitional movements including sit to stand, walking, turning and sit to stand. The test is reported in seconds.

    Week 4 post baseline period

  • Timed Up and Go (TUG) test

    Test involves a series of transitional movements including sit to stand, walking, turning and sit to stand. The test is reported in seconds.

    Week 8 post baseline period

  • Timed Up and Go (TUG) test

    Test involves a series of transitional movements including sit to stand, walking, turning and sit to stand. The test is reported in seconds.

    Week 12 post baseline period

  • The Blue Foam (stand) with Trek Poles Test

    Test involves lateral moves and front and back moves with or without assistance. measures level of assistance needed: supervision or modified assistance.

    Baseline Measure 1 performed at day 1 after signing consent

  • The Blue Foam (stand) with Trek Poles Test

    Test involves lateral moves and front and back moves with or without assistance. measures level of assistance needed: supervision or modified assistance.

    Baseline Measure 2 performed at day 2 after signing consent

  • The Blue Foam (stand) with Trek Poles Test

    Test involves lateral moves and front and back moves with or without assistance. measures level of assistance needed: supervision or modified assistance.

    Week 4 post baseline period

  • The Blue Foam (stand) with Trek Poles Test

    Test involves lateral moves and front and back moves with or without assistance. measures level of assistance needed: supervision or modified assistance.

    Week 8 post baseline period

  • The Blue Foam (stand) with Trek Poles Test

    Test involves lateral moves and front and back moves with or without assistance. measures level of assistance needed: supervision or modified assistance.

    Week 12 post baseline period

  • Parkinson's Disease Questionnaire Short Form (PDQ8)

    This is a spcific health related quality of life instrument created for individuals with Parkinson's Disease. Likert scale (0 - 4), higher the score the greater the functioning. Overall score ranges from 0 -32. Higher scores indicate greater impact of the disease

    Baseline Measure 1 performed at day 1 after signing consent

  • Parkinson's Disease Questionnaire Short Form (PDQ8)

    This is a spcific health related quality of life instrument created for individuals with Parkinson's Disease. Likert scale (0 - 4), higher the score the greater the functioning. Overall score ranges from 0 -32. Higher scores indicate greater impact of the disease

    Baseline Measure 2 performed at day 2 after signing consent

  • Parkinson's Disease Questionnaire Short Form (PDQ8)

    This is a spcific health related quality of life instrument created for individuals with Parkinson's Disease. Likert scale (0 - 4), higher the score the greater the functioning. Overall score ranges from 0 -32. Higher scores indicate greater impact of the disease

    Week 4 post baseline period

  • Parkinson's Disease Questionnaire Short Form (PDQ8)

    This is a spcific health related quality of life instrument created for individuals with Parkinson's Disease. Likert scale (0 - 4), higher the score the greater the functioning. Overall score ranges from 0 -32. Higher scores indicate greater impact of the disease

    Week 8 post baseline period

  • Parkinson's Disease Questionnaire Short Form (PDQ8)

    This is a spcific health related quality of life instrument created for individuals with Parkinson's Disease. Likert scale (0 - 4), higher the score the greater the functioning. Overall score ranges from 0 -32. Higher scores indicate greater impact of the disease

    Week 12 post baseline period

  • Psychological Need Satisfaction in Exercise Scale (PNSES)

    Total range 1-6. Lower scores denotes worse outcome.

    Baseline Measure 1 performed at day 1 after signing consent

  • Psychological Need Satisfaction in Exercise Scale (PNSES)

    Total range 1-6. Lower scores denotes worse outcome.

    Baseline Measure 2 performed at day 2 after signing consent

  • Psychological Need Satisfaction in Exercise Scale (PNSES)

    Total range 1-6. Lower scores denotes worse outcome.

    Week 4 post baseline period

  • Psychological Need Satisfaction in Exercise Scale (PNSES)

    Total range 1-6. Lower scores denotes worse outcome.

    Week 8 post baseline period

  • Psychological Need Satisfaction in Exercise Scale (PNSES)

    Total range 1-6. Lower scores denotes worse outcome.

    Week 12 post baseline period

  • Perceived Stress Scale (PSS-10)

    Total range 0-4. Lower scores denotes worse/better outcome.

    Baseline Measure 1 performed at day 1 after signing consent

  • Perceived Stress Scale (PSS-10)

    Total range 0-4. Lower scores denotes worse/better outcome.

    Baseline Measure 2 performed at day 2 after signing consent

  • Perceived Stress Scale (PSS-10)

    Total range 0-4. Lower scores denotes worse/better outcome.

    Week 4 post baseline period

  • Perceived Stress Scale (PSS-10)

    Total range 0-4. Lower scores denotes worse/better outcome.

    Week 8 post baseline period

  • Perceived Stress Scale (PSS-10)

    Total range 0-4. Lower scores denotes worse/better outcome.

    Week 12 post baseline period

  • Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    completed week 3 after signing consent

  • Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    completed week 4 after signing consent

  • Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    completed week 5 after signing consent

  • Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    completed week 6 after signing consent

  • Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    completed week 7 after signing consent

  • Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    completed week 8 after signing consent

  • Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    completed week 9 after signing consent

  • Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    completed week 10 after signing consent

  • Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    completed week 11 after signing consent

  • Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    completed week 12 after signing consent

  • Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    completed week 13 after signing consent

  • Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    completed week 14 after signing consent

Study Arms (1)

Recreational Therapy Wellness Recovery Program Group

EXPERIMENTAL

All participants will enter a baseline data collection period for two weeks. They will then participate in a 12-week community-based Recreational Therapy (RT) Wellness Recovery Program (WRP) for individuals with Parkinson's disease (WRP).

Behavioral: Wellness Recovery Program

Interventions

12-week community-based recreation therapy

Also known as: WRP
Recreational Therapy Wellness Recovery Program Group

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Potential subjects in this study will have a diagnosis of Parkinson's disease.
  • Potential subjects in this study are able to tolerate a 60-minute exercise program; participants complete the Parkinson Power Moves Class Application which requires a release form and a physician's signature that identifies any limitations or precautions to be taken in the program.

You may not qualify if:

  • Individuals who do not have a diagnosis of Parkinson's disease or those with PD who are not medically cleared to participate in the program will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest University Health Sciences

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

Parkinson DiseaseMovement Disorders

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Peggy Cromer, LRT

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: All participants will enter a 14 week baseline data collection period followed by a 12-week Wellness Recovery Program
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 11, 2019

First Posted

November 15, 2019

Study Start

March 6, 2018

Primary Completion

February 5, 2019

Study Completion

February 5, 2019

Last Updated

March 22, 2023

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations